TRT & Hormone Health Researcher
Morgan specializes in researching testosterone replacement therapy, peptide protocols, and male hormone optimization. With years of dedicated study in exercise science and health education, Morgan translates complex medical research into actionable insights for men seeking to optimize their health.
Areas of expertise
Short-acting injectable testosterone (primarily testosterone cypionate and enanthate) is the most common TRT method in 2025, delivered via intramuscular or subcutaneous injection every 1-2 weeks. While topical gels remain popular, injectables have become the dominant modality in routine U.S. clinical practice due to their efficacy, cost-effectiveness, and patient preference.
TRT typically does not cause erectile dysfunction (ED) when properly administered to hypogonadal men; it usually improves erectile function. However, improper use, particularly supraphysiological dosing or non-medical testosterone use, can suppress natural testosterone production and potentially worsen ED.
No, peptides are not steroids - they are fundamentally different types of molecules with distinct chemical structures and mechanisms of action. While both can be used as performance-enhancing substances, peptides are chains of amino acids while steroids are lipid-based compounds.
Ozempic is primarily used to treat type 2 diabetes in adults and helps manage blood sugar levels while reducing cardiovascular risks in patients with diabetes and heart disease.
TRT may help with weight loss in men with testosterone deficiency by improving body composition, muscle mass, and metabolic health, but results vary between individuals and require medical supervision.
TRT is generally considered safe for long-term use in men with diagnosed hypogonadism when properly monitored, though it requires ongoing medical supervision and individualized dosing to manage potential risks.
About AHF editorial standards: read our editorial methodology.